Yanbin Sun
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Shun Xu (6 shared papers)Shun Xu (3 shared papers)Qiming Shen (2 shared papers)Zhaohua Miao (4 shared papers)Zhengbao Zha (4 shared papers)Xianwen Wang (2 shared papers)Xiaoxi Fan (2 shared papers)Yan Ma (1 shared paper)
- Journals
- BioMed Research International (2 papers)Advanced Healthcare Materials (2 papers)OncoTargets and Therapy (2 papers)Acta Pharmaceutica Sinica B (1 paper)Drug Resistance Updates (1 paper)
- Partner nations
- ChinaUnited StatesVietnam
In The Last Decade
Yanbin Sun
40 papers receiving 673 citations
Peers
Comparison fields: 5 of 93
- Cancer Research 178
- Biomaterials 67
- Molecular Biology 254
- Biomedical Engineering 163
- Immunology 63
Countries citing papers authored by Yanbin Sun
This map shows the geographic impact of Yanbin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanbin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanbin Sun more than expected).
Fields of papers citing papers by Yanbin Sun
This network shows the impact of papers produced by Yanbin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanbin Sun. The network helps show where Yanbin Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanbin Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 126 | |
| 2 | 2017 | 90 | |
| 3 | 2019 | 56 | |
| 4 | 2014 | 49 | |
| 5 | 2018 | 25 | |
| 6 | 2020 | 24 | |
| 7 | 2013 | 24 | |
| 8 | 2025 | 21 | |
| 9 | 2013 | 21 | |
| 10 | 2024 | 19 | |
| 11 | 2022 | 18 | |
| 12 | 2014 | 18 | |
| 13 | 2018 | 18 | |
| 14 | 2015 | 17 | |
| 15 | 2025 | 16 | |
| 16 | 2022 | 14 | |
| 17 | 2020 | 11 | |
| 18 | 2020 | 11 | |
| 19 | 2020 | 11 | |
| 20 | 2020 | 11 |
About Yanbin Sun
Yanbin Sun is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Biomedical Engineering, Materials Chemistry and Oncology, having authored 42 papers that have together received 677 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (6 papers), Immunotherapy and Immune Responses (3 papers), Cancer-related molecular mechanisms research (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Lung Cancer Treatments and Mutations (3 papers), Concrete and Cement Materials Research (2 papers), Cancer Cells and Metastasis (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Cancer Research (178 citations), Biomaterials (67 citations), Molecular Biology (254 citations), Biomedical Engineering (163 citations) and Immunology (63 citations). Yanbin Sun has collaborated with scholars based in China, United States and Vietnam. Frequent co-authors include Shun Xu, Shun Xu, Qiming Shen, Zhaohua Miao, Zhengbao Zha, Xianwen Wang, Xiaoxi Fan, Yan Ma, Liang Cheng and Qianqian Shi. Their work appears in journals such as BioMed Research International, Advanced Healthcare Materials, OncoTargets and Therapy, Acta Pharmaceutica Sinica B and Drug Resistance Updates.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.